Stock ENTREMED INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar EntreMed Inc Nasdaq

Equities

US29382F2020

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for EntreMed Inc
Mar. 28 CASI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 05 Top Midday Gainers MT

Chart calendar EntreMed Inc

86868c665cbd2e8639569898a642fa.nUHRUksmfmsc6GFQ6pjJOnGjaiMTwnmQ3q1MoUnMn6M.ywyQZzNPORJ42gQRhOqseAHwLU508wzThoAP4zCm9sikDrc6OBcfDlueLA~444b88b87824346e774b249c2429f209

Upcoming events on EntreMed Inc

2024-05-19 Q1 2024 Earnings Release
2024-08-08 Q2 2024 Earnings Release (Projected)
2024-11-11 Q3 2024 Earnings Release (Projected)
2025-04-22 Q4 2024 Earnings Release (Projected)
2025-05-13 Q1 2025 Earnings Release (Projected)

Past events on EntreMed Inc

2024-03-28 07:00 am Q4 2023 Earnings Release
2023-11-14 07:00 am Q3 2023 Earnings Release
2023-08-11 07:00 am Q2 2023 Earnings Release
2023-05-16 Q1 2023 Earnings Release
2023-04-25 Q4 2022 Earnings Release
2022-11-14 07:00 am Q3 2022 Earnings Release
2022-08-12 08:00 am Interim 2022 Earnings Call
2022-08-12 07:00 am Interim 2022 Earnings Release
2022-06-01 Reverse Split: 1 of 10
2022-05-25 09:00 am Annual General Meeting
2022-05-12 08:00 am Q1 2022 Earnings Call
2022-05-12 07:00 am Q1 2022 Earnings Release
2022-03-28 08:00 am FY 2021 Earnings Call
2022-03-28 07:00 am FY 2021 Earnings Release
2021-12-11 05:30 pm American Society of Hematology Virtual Meeting and Exposition
2021-11-17 Jefferies London Healthcare Conference
2021-11-12 08:00 am Q3 2021 Earnings Call
2021-11-12 07:00 am Q3 2021 Earnings Release
2021-09-21 12:05 pm Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
2021-08-12 08:00 am Interim 2021 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		4,13
7,82
-47.16%		15,1
14,7
3.05%		30,2
30,1
0.29%		43,1
38,7
11.51%		33,9
36,4
-6.97%
59,2

EBITDA
Million USD		Released
Forecast
Spread 		-32,2
-32,1
-0.3%		-31,7
-32,4
1.91%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-40,0
-37,8
-5.75%		-33,7
-39,8
15.24%		-41,8
-37,6
-11.12%		-34,0
-27,6
-23.26%		-25,1
-25,1
-0%
0,05

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-45,4
-40,4
-12.36%		-47,5
-39,9
-19.05%		-35,8
-37,9
5.44%		-37,4
-27,3
-37.08%		-26,3
-25,6
-2.52%
0,05

Net income
Million USD		Released
Forecast
Spread 		-46,0
-40,9
-12.54%		-48,3
-41,7
-15.71%		-36,7
-42,2
13.09%		-41,0
-26,5
-55.02%		-27,0
-26,0
-3.54%
0,04

EPS
USD		Released
Forecast
Spread 		-4,80
-4,14
-15.97%		-4,40
-3,79
-16.24%		-2,70
-3,03
10.99%		-3,01
-1,65
-82.42%		-2,02
-1,93
-4.66%
0,00

Announcement Date16/03/2030/03/2128/03/2226/04/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		9,16
9,06
1.13%		9,06
9,24
-1.96%		8,57
7,87
8.91%		10,2
9,91
3.05%		15,3
10,8
41.18%		8,35
9,10
-8.27%		9,82
10,1
-2.68%		8,84
10,4
-15.25%		6,87
9,41
-26.97%
12,0


13,8


15,5


17,8

EBIT
Million USD		Released
Forecast
Spread 		-11,4
-7,20
-58.85%		-7,29
-13,1
44.24%		-7,75
-9,46
18.12%		-6,35
-7,61
16.54%		-12,6
-6,22
-103.21%


-9,35
-6,84
-36.7%		-5,10
-7,66
33.5%		-3,43
-3,26
-5.19%











Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-4,79
-7,10
32.54%		-8,40
-12,0
29.88%		-7,49
-8,73
14.18%		-5,02
-6,88
27.03%		-16,5
-5,23
-216.02%


-10,1
-6,84
-47.09%		-4,45
-7,66
41.91%		-5,97
-3,26
-83.3%











Net income
Million USD		Released
Forecast
Spread 		-5,60
-8,30
32.52%		-8,60
-12,1
28.75%		-7,68
-8,79
12.6%		-5,20
-6,93
24.92%		-19,5
-5,25
-272.42%


-10,2
-6,84
-49.78%		-4,64
-7,66
39.51%		-6,08
-3,26
-86.53%











EPS
USD		Released
Forecast
Spread 		-0,40
-0,57
29.41%		-0,60
-0,87
30.77%		-0,56
-0,64
12.5%		-0,38
-0,46
17.99%		-1,44
-0,37
-289.19%		-0,45
-0,64
29.69%		-0,77
-0,50
-54%		-0,35
-0,56
37.5%		-0,46
-0,24
-91.67%
-0,05


-0,01


0,01


0,03

Announcement Date28/03/2212/05/2212/08/2214/11/2226/04/2317/05/2311/08/2314/11/2328/03/24----

Upcoming sector events for EntreMed Inc

2024-04-28 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-28 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q4 2023 Earnings Release
2024-04-28 BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-28 JIANGXI FUSHINE PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-28 AURISCO PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
2024-04-28 PT TEMPO SCAN PACIFIC TBK: Q1 2024 Earnings Release (Projected)
2024-04-28 SICHUAN HUIYU PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-28 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-28 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-28 WEDGE INDUSTRIAL CO.,LTD.: Q1 2024 Earnings Release
More events

Past sector events for EntreMed Inc

2024-04-26 LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q4 2023 Earnings Release
2024-04-26 NANJING VAZYME BIOTECH CO.,LTD: Q4 2023 Earnings Release
2024-04-26 LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q1 2024 Earnings Release
2024-04-26 HUNAN ER-KANG PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
2024-04-26 ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-26 GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release
2024-04-26 GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q4 2023 Earnings Release
2024-04-26 NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
2024-04-26 ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-26 ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
  1. Stock Market
  2. Equities
  3. CASI Stock
  4. Stock
  5. Calendar EntreMed Inc